Evidence Generation Department, HARTMANN GROUP, Heidenheim, Germany.
Institute of Public Health, Medical Decision Making and HTA, Hall in Tirol, Austria.
Int Wound J. 2024 Mar;21(3):e14750. doi: 10.1111/iwj.14750.
Effective exudate management is key for optimal ulcer healing. Superabsorbent dressings are designed to have high fluid handling capacity, reduced risk of exudate leakage, fluid retention under compression, and to sequester harmful exudate components. This study aimed to systematically identify existing evidence for the clinical efficacy and cost-effectiveness of superabsorbent dressings for the treatment of moderate-to-highly exudating chronic ulcers of various etiologies. The aim is focused on examining the 'class' effect of all superabsorbers, not any particular dressing. Clinical and cost effectiveness systematic reviews were conducted, searching Embase, MEDLINE, the Cochrane Library, and the Cumulative Index to Nursing and Allied Health Literature. The Cost Effectiveness Analysis Registry and Econ papers were also searched for the economic review. Outcomes of interest included ulcer closure, dressing properties, hospital- and infection-related outcomes, safety, and economic outcomes. Fourteen studies were included in the clinical systematic review. Eleven were case series, with one randomised controlled trial, one retrospective matched observational study, and one retrospective cohort study. The studies investigated eight superabsorbent dressings and were heterogeneous in their patient population and outcomes. Superabsorbent dressings may result in favourable outcomes, including reductions in frequency of dressing change and pain scores. As most studies were case series, drawing firm conclusions was difficult due to absence of a comparator arm. The economic systematic review identified seven studies, five of which were cost-utility analyses. These suggested superabsorbent dressings are a more cost-effective option for the treatment of chronic ulcers compared with standard dressings. However, the small number and low quality of studies identified in both reviews highlights the need for future research.
有效的渗出液管理是促进溃疡愈合的关键。高吸水性敷料的设计具有高的液体处理能力、降低渗出液泄漏的风险、在压缩下保留液体以及隔离有害渗出液成分的能力。本研究旨在系统地确定高吸水性敷料治疗各种病因的中重度渗出性慢性溃疡的临床疗效和成本效益的现有证据。目的是集中检查所有高吸水性剂的“类别”效果,而不是任何特定的敷料。进行了临床和成本效益系统评价,检索了 Embase、MEDLINE、Cochrane 图书馆和 Cumulative Index to Nursing and Allied Health Literature。还在 Cost Effectiveness Analysis Registry 和 Econ papers 中搜索了经济评价。感兴趣的结果包括溃疡愈合、敷料特性、医院和感染相关结局、安全性和经济结果。临床系统评价纳入了 14 项研究。其中 11 项为病例系列研究,包括 1 项随机对照试验、1 项回顾性匹配观察性研究和 1 项回顾性队列研究。这些研究调查了 8 种高吸水性敷料,患者人群和结局存在异质性。高吸水性敷料可能会产生有利的结果,包括减少更换敷料的频率和疼痛评分。由于大多数研究为病例系列研究,由于缺乏对照臂,因此难以得出确定的结论。经济系统评价确定了 7 项研究,其中 5 项为成本效用分析。这些研究表明,与标准敷料相比,高吸水性敷料是治疗慢性溃疡的更具成本效益的选择。然而,在这两项综述中,研究数量少且质量低,这突出表明需要开展更多的研究。